Chronic viral hepatitis: The histology report

Digestive and Liver Disease

Volumn 43, Issue SUPPL. 4, 2011, Pages

  Guido, Maria ^a   Mangia, Alessandra ^b   Faa, Gavino ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Chronic viral hepatitis; GIPAD report; Liver biopsy; Scoring systems

Indexed keywords

ALANINE AMINOTRANSFERASE; PEGINTERFERON; RIBAVIRIN; VIRUS DNA;

ARTICLE; BODY MASS; CHRONIC HEPATITIS; HEPATITIS A; HEPATITIS B; HEPATITIS C; HUMAN; INSULIN RESISTANCE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; PRIORITY JOURNAL; REPRODUCIBILITY; SCORING SYSTEM; STEATOSIS; VIRUS HEPATITIS;

ANTIGENS, VIRAL; BIOPSY; COMORBIDITY; FATTY LIVER; HEPACIVIRUS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; IRON; LIVER; LIVER CIRRHOSIS; OBSERVER VARIATION; PATHOLOGY; SELECTION BIAS; SEVERITY OF ILLNESS INDEX;

EID: 79953212588     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(11)60589-6     Document Type: Article

References (98)

1. von Frerichs FT Uber den Diabetes 1884, Hirschwald, Berlin.
2. Menghini G One-second needle biopsy of the liver. Gastroenterology 1958, 35:190-195.
3. De Groote J, Desmet VJ, Gedigk P, et al. A classification of chronic hepatitis. Lancet 1968, 2:626-628.
4. International group Acute and chronic hepatitis revisited. Lancet 1977, 29:914-919.
5. Schmid M, Flury R, Buhler H, et al. Chronic viral hepatitis B and C: an argument against the conventional classification of chronic hepatitis. Virchows Arch 1994, 425:221-226.
6. Ludwig J The nomenclature of chronic active hepatitis: an obituary. Gastroenterology 1993, 105:274-278.
7. Gerber MA Chronic hepatitis C: the beginning of the end of a time honored nomenclature?. Hepatology 1992, 15:733-734.
8. Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994, 19:1513-1520.
9. Brunt EM Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology 2000, 31:241-246.
10. Lok AS, McMahon BJ Chronic hepatitis B. Hepatology 2007, 45:507-539.
11. Lavanchy D Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004, 11:97-107.
12. Zanetti AR, Romano L, Zappa A, et al. Changing patterns of hepatitis B infection in Italy and NAT testing for improving the safety of bloody supply. J Clin Virol 2006, 36(Suppl 1):51-55.
13. Te HS, Jensen DM Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis 2010, 14:1-21.
14. Bialek SR, Terrault NA The changing epidemiology and natural history of hepatitis C virus infection. Clin Liver Dis 2006, 10:697-715.
15. Mangia A, Antonucci F, Brunetto M, et al. Italian Association for the Study of the Liver (AISF). The use of molecular assays in the management of viral hepatitis. Dig Liver Dis 2008, 40:395-404.
16. Fattovich G, Bortolotti F, Donato F Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 2008, 48:335-352.
17. Holomán J, Glasa J EASL clinical practice guidelines. J Hepatol 2009, 51(4):821-822.
18. Loomba R, Ling TJ Treatment of chronic hepatitis B. Antivir Ther 2007, 12(Suppl 3):33-41.
19. Keefe EB, Marcellin P New and emerging treatment of chronic hepatitis B. Clin Gastroenterol Hepatol 2007, 5:285-294.
20. Strader DB, Wright T, Thomas DL, American Association for the Study of Liver Diseases, et al. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004, 39:1147-1171.
21. Pawlotsky JM Hepatitis C virus genetic variability: Pathogenic and clinical implications. Clin Liver Dis 2003, 7:45-66.
22. EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. Consensus statement. J Hepatol 1999, 31(Suppl 1):3-8.
23. Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. Italian Association for the Study of the Liver; Italian Society of Infectious, Tropical Diseases; Italian Society for the Study of Sexually Transmitted Diseases. Dig Liver Dis 2010, 42:81-91.
24. Theise ND, Bodenheimer HC, Ferrell LD Acute and chronic viral hepatitis. MacSween's Pathology of the Liver 2007, 399-441. Churchill Livingstone, Philadelphia. 5th ed. A.D. Burt, B.C. Portmann, L.D. Ferrell (Eds.).
25. Ishak KG Pathologic features of chronic hepatitis. A review and update. Am J Clin Pathol 2000, 113:40-55.
26. Scheuer PJ, Lefkowitch JH Liver Biopsy Interpretation 2006, Saunders, Philadelphia. 7th ed.
27. Hadziyannis S, Gerber MA, Vissoulis C, et al. Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers. Arch Pathol 1973, 96:327-330.
28. Lefkowitch JH, Lobritto SJ, Brown RS, et al. Ground-glass, polyglucosan-like hepatocellular inclusions: A "new" diagnostic entity. Gastroenterology 2006, 131(3):713-718.
29. Scheuer PJ, Ashrafzadeh P, Sherlock S, et al. The pathology of hepatitis C. Hepatology 1992, 15:567-571.
30. Knodell KG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981, 1:431-435.
31. Scheuer PJ Scoring of liver biopsies: are we doing it right?. Eur J Gastroenterol Hepatol 1996, 8:1141-1143.
32. Hübscher SG Histological grading and staging in chronic hepatitis: clinical applications and problems. J Hepatol 1998, 29:1015-1022.
33. Desmet VJ Knodell RG, Ishak KG, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis [Hepatology 1981;1:431-5]. J Hepatol 2003, 38:382-386.
34. Scheuer PJ Classification of chronic viral hepatitis: a need for a reassessment. J Hepatol 1991, 13:372-374.
35. METAVIR Cooperative Study Group An algorithm for the grading of activity in chronic hepatitis. Hepatology 1996, 24:289-293.
36. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995, 22:696-699.
37. Hytiroglou P, Thung SN, Gerber MA Histological classification and quantification of the severity of chronic hepatitis: Keep it simple!. Sem Liv Dis 1995, 15:414-421.
38. Thiese N Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach. Mod Pathol 2007, 20:S3-S14.
39. Goodman Z Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol 2007, 47:598-607.
40. Guido M, Rugge M Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis 2004, 24:89-97.
41. Colloredo G, Guido M, Sonzogni A, et al. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003, 39:239-244.
42. Bedossa P, Dargere D, Paradis V Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003, 38:1449-1457.
43. Brunetti E, Silini E, Pistorio A, et al. Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis. J Hepatol 2004, 40:501-506.
44. Geller SA, Pitman MB Morphological diagnostic procedures (liver biopsy). Pathology of the liver 2002, 943-960. Churchill Livingston, London. R.N.M. Mc Sween, A.D. Burt, B.C. Portmann (Eds.).
45. Guido M, Rugge M Liver fibrosis: natural history may be affected by the biopsy sample. Gut 2004, 53:1878.
46. Colombo M, Del Ninno E, de Franchis R, et al. Ultrasound-assisted percutaneous liver biopsy: superiority of the Tru-Cut over the Menghini needle for diagnosis of cirrhosis. Gastroenterology 1988, 95:487-489.
47. Sherman KE, Goodman ZD, Sullivan ST, et al. Liver biopsy in cirrhotic patients. Am J Gastroenterol 2007, 102:789-793.
48. Cholongitas E, Quaglia A, Samonakis D, et al. Transjugular liver biopsy: how good is it for accurate histological interpretation?. Gut 2006, 55:1789-1794.
49. Hunt N, Fleming K Reproducibility of liver biopsy grading and staging. Liver 1999, 19:169-170.
50. Guido M, Colloredo G, Fassan M, et al. Clinical practice and ideal liver biopsy sampling standards: Not just a matter of centimetres. J Hepatol 2006, 44:823-824.
51. Rockey DC, Caldwell SH, Goodman ZD, et al. Liver biopsy. Hepatology 2009, 43:1017-1044.
52. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002, 97:2614-2816.
53. Goldin RD, Goldin GJ, Burt AD, et al. Intra-observer and interobserver variation in the histopathological assessment of chronic viral hepatitis. J Hepatol 1996, 25:649-654.
54. Westin J, Lagging LM, Weistal R, et al. Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. Liver 1999, 19:183-187.
55. Gronbek K, Christensen PB, Hamilton-Dutoit S, et al. Interobserver variation in interpretation of serial liver biopsies from patients with chronic hepatitis. C. J Viral Hep 2002, 9:443-449.
56. METAVIR cooperative group Inter- and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C. Hepatology 1994, 20:15-20. 1:.
57. Rousselet MC, Michalak S, Dupré F, et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005, 41:257-264.
58. Negro F Mechanisms and significance of liver steatosis in hepatitis C virus infection. World J Gastroenterol 2006, 12:6756-6765.
59. Castéra L, Hézode C, Roudot-Thoraval F, et al. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. Gut 2003, 52:288-292.
60. Leandro G, Mangia A, Hui J, et al. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology 2006, 130:1636-1642.
61. Adinolfi L, Gambradella M, Andreana A, et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV gGenotype and visceral obesity. Hepatology 2001, 33:1358-1364.
62. Negro F, Clement S Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C. J Vir Hepat 2009, 16:681-688.
63. Westin J, Lagging M, Dhillon AP, et al. Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection. J Viral Hepat 2007, 14:29-35.
64. Thomopoulos KC, Arvaniti V, Athanasios C, et al. Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis. Eur J Gastroenterol Hepatol 2006, 18:233-237.
65. Peng D, Han Y, Ding H, et al. Hepatic steatosis in chronic hepatitis B is associated with metabolic factors more than viral factors. J Gastroenterl Hepatol 2008, 23:1082-1088.
66. Merriman RB, Ferrell LD, Patti MG, et al. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 2006, 44:874-880.
67. El-Badry AM, Breitenstein S, Jochum W, et al. Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 2009, 250:691-697.
68. Corengia C, Galimberti S, Bovo G, et al. Iron accumulation in chronic hepatitis C. Am J Clin Pathol 2005, 124:846-853.
69. Girelli D, Pasino M, Goodnough JB, et al. Reduced serum hepcidin levels in patients with chronic hepatitis C. J Hepatol 2009, 51:845-852.
70. Chapoutot C, Esslimani M, Joomaye Z, et al. Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis. Gut 2000, 46:711-714.
71. Pietrangelo A Metals, oxidative stress, and hepatic fibrogenesis. Semin Liver Dis 1996, 16:13-30.
72. Angelucci E, Muretto P, Nicolucci A, et al. Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. Blood 2002, 100:17-21.
73. Olynyk JK, Reddy KR, Di Bisceglie AM, et al. Hepatic iron concentration as a predictor of response to interferon-alfa therapy in chronic hepatitis-C. Gastroenterology 1995, 108:1104-1109.
74. Ferrara F, Ventura P, Vegetti A, et al. Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C. Am J Gastroenterol 2009, 104:605-616.
75. Di Bisceglie AM, Bonkovsky HL, Chopra S, et al. Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial. Hepatology 2000, 32:135-138.
76. Kageyama F, Kobayashi Y, Kawasaki T, et al. Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C. Am J Gastroenterol 2000, 95:1041-1050.
77. Fontana RJ, Israel J, LeClair P, et al. Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, control trial. Hepatology 2000, 31:730-736.
78. Piperno A, Sampietro M, D'Alba, et al. Iron stores, response to alphainterferon therapy, and effects of iron depletion in chronic hepatitis C. Liver 1996, 16:248-254.
79. Fargion S, Fracanzani AL, Rossini A, et al. Iron reduction and sustained response to interferon-a therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study. Am J Gastroenterol 2002, 97:1204-1210.
80. Kato J, Kobune M, Nakamura T, et al. Normalization of elevated hepatic 8-hydroxy-20-deoxyguanosine level in chronic hepatitis C patients by phlebotomy and low iron diet. Cancer Res 2001, 61:8697-8702.
81. Searle J, Leggett BA, Crawford DHG, et al. Iron storage diseases. Pathology of the liver 2002, 943-960. Churchill Livingston, London. R.N.M. Mc Sween, A.D. Burt, B.C. Portmann, K.I. Ishak, P.J. Scheuer, P.P. Anthony (Eds.).
82. Deugnier YM, Loreal O, Turlin B, et al. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 1992, 102:2050-2059.
83. Anthony PP, Vogel CL, Barker LF Liver cell dysplasia: a premalignant condition. J Clin Pathol 1973, 26:217-223.
84. Park NY, Roncalli M Large liver cell dysplasia: a controversial entity. J Hepatol 2006, 45:734-743.
85. Watanabe S, Okita K, Harada T, et al. Morphologic studies of liver cell dysplasia. Cancer 1983, 51:2197-2205.
86. Borzio M, Bruno S, Roncalli M, et al. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology 1995, 108:812-817.
87. Le Bail B, Bernard PH, Carles J, et al. Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants. J Hepatology 1997, 27:835-842.
88. Ganne-Carrie N, Chastang C, Chapel F, et al. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Hepatology 1996, 23:1112-1118.
89. Libbrecht L, Craninx M, Nevens F, et al. Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis. Histopathology 2001, 39:66-73.
90. Koo JS, Kim H, Park BK, et al. Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with chronic hepatitis B. J Clin Gastroenterol 2008, 42:738-743.
91. Marchio A, Terris B, Meddeb M, et al. Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation. Mol Pathol 2001, 54:270-274.
92. Hytiroglou P, Park YN, Krinsky G, et al. Hepatic precancerous lesions and small hepatocellular carcinoma. Gastroenterol Clin North Am 2007, 36:867-887.
93. Naoumov NV, Portmann BC, Tedder RS, et al. Detection of hepatitis B virus antigens in liver tissue. A relation to viral replication and histology in chronic hepatitis B infection. Gastroenterology 1990, 99:1248-1253.
94. Park YN, Han KH, Kim KS, et al. Cytoplasmic expression of hepatitis B core antigen in chronic hepatitis B virus infection: role of precore stop mutants. Liver 1999, 19:199-205.
95. Nair V, Fischer SE, Adeyi OA Non-viral-related pathologic findings in liver needle biopsy specimens from patients with chronic viral hepatitis. Am J Clin Pathol 2010, 133:127-132.
96. Clouston AD, Powell EE Interaction of non-alcoholic fatty liver disease with other liver diseases. Best Pract Res Clin Gastroenterol 2002, 16:767-781.
97. Ong JP, Younossi ZM, Speer C, et al. Chronic hepatitis C and superimposed nonalcoholic fatty liver disease. Liver 2001, 21:266-271.
98. Bedossa P, Moucari R, Chelbi E, et al. Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective study. Hepatology 2007, 46:380-387.